Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 4.99B | 5.25B | 3.74B | 3.02B | 3.09B |
Gross Profit | 3.19B | 3.50B | 3.47B | 3.35B | 2.38B |
EBITDA | 984.00M | 1.23B | 1.57B | 1.59B | 729.00M |
Net Income | 698.00M | 881.00M | 1.15B | 1.17B | 497.00M |
Balance Sheet | |||||
Total Assets | 79.30B | 85.83B | 85.41B | 94.62B | 88.13B |
Cash, Cash Equivalents and Short-Term Investments | 14.18B | 26.77B | 25.45B | 39.86B | 30.97B |
Total Debt | 6.67B | 9.77B | 6.24B | 2.80B | 5.73B |
Total Liabilities | 72.75B | 79.43B | 80.22B | 86.72B | 80.08B |
Stockholders Equity | 6.54B | 6.41B | 5.18B | 7.90B | 8.05B |
Cash Flow | |||||
Free Cash Flow | 448.00M | 1.10B | 556.00M | 564.00M | 849.00M |
Operating Cash Flow | 601.00M | 1.25B | 638.00M | 634.00M | 928.00M |
Investing Cash Flow | 3.26B | 3.49B | -9.95B | 1.72B | -4.60B |
Financing Cash Flow | -6.56B | -1.52B | -7.08B | 4.55B | 13.62B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $8.56B | 12.09 | 11.60% | 1.52% | 4.74% | 10.10% | |
79 Outperform | $9.71B | 11.86 | 9.34% | 2.74% | 4.73% | 7.12% | |
76 Outperform | $8.89B | 13.30 | 11.07% | 4.18% | -8.62% | 15.37% | |
73 Outperform | $8.13B | 13.61 | 15.34% | 3.05% | 4.04% | 13.30% | |
72 Outperform | $9.26B | 11.04 | 12.58% | 1.84% | 7.14% | 14.94% | |
68 Neutral | $7.25B | 12.38 | 9.32% | 1.01% | 10.19% | 48.39% | |
58 Neutral | HK$112.05B | 6.02 | -4.20% | 3.95% | 9.29% | -46.28% |
On August 11, 2025, Comerica Incorporated issued and sold 16,000,000 depositary shares, each representing a 1/40th ownership interest in a share of 6.875% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series B. This issuance followed the filing of a Certificate of Designations with the Secretary of State of Delaware on August 7, 2025, establishing the terms of the Series B Preferred Stock. The company entered into an Underwriting Agreement on August 4, 2025, with several major financial institutions to facilitate the sale, resulting in net proceeds of approximately $392.2 million. This strategic financial maneuver is expected to impact Comerica’s capital structure and potentially influence its market positioning.
The most recent analyst rating on (CMA) stock is a Sell with a $50.00 price target. To see the full list of analyst forecasts on Comerica stock, see the CMA Stock Forecast page.
Comerica announced that key executives will present at the 2025 Morgan Stanley US Financials Conference on June 11, 2025. The presentation will highlight Comerica’s strategic initiatives aimed at driving sustainable revenue growth and enhancing its market position. The company emphasizes its commitment to leveraging its strong foundation and differentiated strategy to achieve responsible growth and deliver enhanced returns over time.
The most recent analyst rating on (CMA) stock is a Sell with a $50.00 price target. To see the full list of analyst forecasts on Comerica stock, see the CMA Stock Forecast page.
On June 10, 2025, Comerica Incorporated announced its decision to redeem all 4,000 outstanding shares of its 5.625% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series A, along with the corresponding depositary shares, on July 1, 2025. This strategic move, which follows the satisfaction of all regulatory requirements, will involve a redemption price of $1,000 per depositary share, excluding declared and unpaid dividends, and will be executed through The Depository Trust Company with Computershare Inc. and Computershare Trust Company, N.A. acting as the redemption agent.
The most recent analyst rating on (CMA) stock is a Sell with a $50.00 price target. To see the full list of analyst forecasts on Comerica stock, see the CMA Stock Forecast page.
On May 8, 2025, Brian S. Goldman announced his resignation as Senior Executive Vice President and Chief Risk Officer of Comerica, effective May 23, 2025, to pursue another opportunity. His departure was amicable, and Comerica is searching for a permanent replacement. Meanwhile, Melinda A. Chausse will take on the role of Chief Risk Officer on an interim basis, ensuring continuity in risk management operations.
The most recent analyst rating on (CMA) stock is a Sell with a $50.00 price target. To see the full list of analyst forecasts on Comerica stock, see the CMA Stock Forecast page.